guanethidine has been researched along with vasoactive intestinal peptide (10-28) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, F; Niioka, S; Nishio, H; Okishio, Y; Takeuchi, T; Yamaji, M; Yamazaki, Y | 1 |
1 other study(ies) available for guanethidine and vasoactive intestinal peptide (10-28)
| Article | Year |
|---|---|
Mediators of nonadrenergic, noncholinergic relaxation in Sprague Dawley rat intestine: comparison with the mediators of other strains.
Topics: Animals; Atropine; Colon; Enzyme Inhibitors; Gastrointestinal Motility; Guanethidine; Ileum; Jejunum; Muscle Contraction; Muscle Relaxation; Neuropeptides; Nitric Oxide; Nitroarginine; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Sprague-Dawley; Rats, Wistar; Species Specificity; Vasoactive Intestinal Peptide | 2000 |